Related Experiment Video
Updated: Jun 2, 2026

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
Published on: November 13, 2016
[Correlation between capillary fasting glucose and HbA1c: study on 181 type 2 diabetics patients in Democratic
J R Makulo1, N M Nseka, F B Lepira
1Département de médecine interne, Cliniques universitaires, Kinshasa, RD Congo. Jrmakulo@yahoo.fr
Insights
Average capillary fasting glucose (CFG) from four tests, spaced two weeks apart, strongly correlates with HbA1c for type 2 diabetes monitoring. This offers a viable alternative in resource-limited settings lacking HbA1c testing equipment.
Area of Science:
- Endocrinology
- Clinical Chemistry
- Diabetology
Background:
- Diabetic patient monitoring in Congolese hospitals is limited by equipment availability, relying on capillary fasting glucose (CFG) or plasmatic glucose.
- HbA1c provides a long-term glycemic control measure, crucial for diabetes management.
Purpose of the Study:
- To evaluate the correlation between HbA1c and CFG in type 2 diabetic patients.
- To determine if average CFG can serve as a reliable substitute for HbA1c testing in resource-constrained environments.
Main Methods:
- A study involving 181 type 2 diabetic patients at the University Hospital of Kinshasa.
- Four CFG tests were conducted bi-weekly, alongside one HbA1c test using an immunoassay method.
- Pearson correlation coefficient (r) and simple linear regression were employed to analyze the data.
Main Results:
- HbA1c showed the strongest correlation with the average CFG of four tests (r = 0.753, p < 0.001).
- Correlation was weaker with individual CFG tests performed at different time points.
- A linear regression model indicated that a 1.925 mmol/L increase in average CFG corresponds to a 1% increase in HbA1c.
Conclusions:
- Average CFG, derived from four bi-weekly tests, is well-correlated with HbA1c in type 2 diabetic patients.
- Average CFG presents a practical and effective alternative for monitoring type 2 diabetes in facilities without HbA1c testing capabilities.
Objectives:
Due to lack of equipment, diabetic patients in Congolese hospitals are monitored only by capillary (CFG) or plasmatic fasting glucose. The purpose of this study was to estimate the correlation between the HbA1c and CFG in type 2 diabetic patients.
Methods:
From July 1st to October 30th, 2007, four CFG tests (one every two weeks) and one HbA1c test (immunoassay method) were performed in 181 type 2 diabetics managed at the University Hospital of Kinshasa. Correlation between the HbAlc test and each CFG test was determined by Pearson coefficient (r). Variation of HbA1c according to the average CFG was determined by simple linear regression.
Results:
Duration of diabetes varied between 1 and 32 years (median: 4 years). Patients had an average age of 56.4 +/- 11.2 years of age; a mean CFG of 9.38 +/- 3.62 mmol/L and HbA1c of 9.4 +/- 2.7%. HbA1c correlated better with average CFG (r = 0.753, p < 0.001) than with CFG performed 4 weeks earlier (r = 0.714, p < 0.001), 6 weeks earlier (r= 0.649, p < 0.001), 2 weeks earlier (r = 0.646, p < 0.001) and concomitantly (r = 0.636, p < 0.001). Extrapolation based on the linear regression equation showed that a delta of 1.925 mmol/L in average CFG = D 1% HbA1c.
Conclusion:
In the type 2 diabetic patients in this study, average CFG of 4 tests carried out at 2-week intervals was well correlated to the HbAlc. Average CFG seems a good alternative for monitoring type 2 diabetes in environments not equipped for HbAlc testing.
Related Concept Videos
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Hyperglycemia
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Hypoglycemia
Type I Diabetes II: Pathophysiology
